MENU
ATXS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Astria Therapeutics (ATXS) Ownership - Who owns Astria Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
75 State Street
Phone
+1 617 349-1971
Employees
59
Web
https://www.astriatx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
599.8M
P/E Ratio
N/A
Total Cash
18.58M
Projected Growth
N/A
Total Debt
168K
Revenue
N/A
Risk (Beta)
0.19
Dividend Yield
N/A
Total Cash/Share
0.33
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ATXS
Capitalization
600M
P/E Ratio
N/A
Risk (Beta)
0.19
Dividend Yield
N/A
Total Cash
18.6M
Total Cash/Share
0.33
Total Debt
168K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
272M
P/B Ratio
2.38
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
55K
Current Ratio
33.83
Current Revenue Per Employee
6944.44
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
721M
Shares Outstanding - Current
56.4M
Total Liabilities
11.1M
Total Volume MTD
N/A
Value
N/A
Gain YTD
38.151
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of new medicines for the treatment of cardiovascular, metabolic and inflammatory diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
75 State Street
Phone
+1 617 349-1971
Employees
59
Web
https://www.astriatx.com